Skip to main content
EJNMMI Research
Fig. 3 | EJNMMI Research

Fig. 3

From: Detection and therapy of neuroblastoma minimal residual disease using [64/67Cu]Cu-SARTATE in a preclinical model of hepatic metastases

Fig. 3

Biodistribution of 64Cu-SARTATE in mice-bearing IMR32 intrahepatic metastases. a PET images were analyzed using AMIDE (n = 4–7). b Data from ex vivo analysis of tissues at 24 h (n = 3) and 48 h (n = 4) post-injection. (Means ± SD). c Following exposure to phosphor storage plates and staining, regions of tissue samples were analyzed using ImageJ. Radionuclide uptake in liver, tumor and necrotic tumor are shown (10th percentile, mean and 90th percentile data). No tumor was detected in sample #6, and no necrotic tumor was detected in samples #3 or 4

Back to article page